Filing Details
- Accession Number:
- 0000899243-20-031557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 19:43:50
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-18 19:43:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779990 | Thomas Michael Henderson | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-16 | 10,000 | $1.05 | 277,751 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-16 | 10,000 | $45.00 | 267,751 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-16 | 12,813 | $0.00 | 280,564 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-16 | 6,353 | $44.33 | 274,211 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-16 | 10,000 | $0.00 | 10,000 | $1.05 |
| Common Stock | Restricted Stock Units | Disposition | 2020-11-16 | 12,813 | $0.00 | 12,813 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,282 | 2020-05-19 | 2029-09-24 | No | 4 | M | Direct |
| 179,375 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 18, 2020.
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 12,813 shares of Common Stock underlying the Reporting Person's RSUs.
- The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. 6.25% of the RSUs vested on August 16, 2020 and November 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.
Billionaire Hedge Funds
